Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer.
about
Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic eventEarly discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropeniaUpdated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropeniaExploring the association of hemoglobin level and adverse events in children with cancer presenting with fever in neutropeniaWhich decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis.Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancerRepeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implicationsPredicting infectious complications in neutropenic children and young people with cancer (IPD protocol).Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.The evolution towards ambulatory and day-case management of febrile neutropenia.Beta-herpesviruses in febrile children with cancerSystematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services.Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study.Antibiotic use during infectious episodes in the first 6 months of anticancer treatment-A Swedish cohort study of children aged 7-16 years.Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting.Characteristics of Children With Cancer Discharged or Admitted From the Emergency Department.The reporting of outcomes in studies of fever and neutropenia in children with cancer: time for consensus.Serial procalcitonin levels to detect bacteremia in febrile neutropenia.Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.Prospective audit of treatment of paediatric febrile neutropenia in Australasia.Evaluation of malnutrition as a predictor of adverse outcomes in febrile neutropenia associated with paediatric haematological malignancies.Predictive Indicators to Identify High-Risk Paediatric Febrile Neutropenia in Paediatric Oncology Patients in a Middle-Income Country.Predictive factors for blood stream infections in children with cancer.Health-related quality of life relates to school attendance in children on treatment for cancer.Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012.
P2860
Q24236088-7F691062-75B0-4595-9B8F-024C06330F21Q24811109-340B1397-B57F-4FDB-94C0-F38683ACFA69Q28729011-FD21206B-F3A6-4E44-A6BB-E6DED22F7910Q33895962-4FAA99EA-7D7E-423B-A0BE-0EEC6FBAD85CQ35197214-9EF1C525-6842-42A5-AB30-6D8E7D39E985Q35469953-6272C594-FCE1-4BB6-B9B0-F01B3D5F4FA9Q35788342-4F200640-B6EE-4A62-91F0-994BE482052CQ35958125-6F4A0A26-809E-47CB-A192-FBD7B11C30AFQ36241163-596CB141-72EE-4735-AC37-B2F5A2D5792CQ36573955-ECE9B939-660D-49C9-8492-73CA9970F54AQ36944956-0212D5DC-ED96-4702-96DF-4A6232017DFCQ37771732-51D6A9C8-BF0D-4797-A5E3-134DA42B677AQ38652240-BE2DCDED-377D-4C92-B2FF-36CAC9CED42DQ38678458-76781770-26EE-435D-A555-E2B2A2F6811BQ38727814-F47D1B4E-D023-4681-8EF0-D59A6CFEE15DQ38838351-D2F6A418-2627-4662-96E4-7B7C758FFAD0Q38984766-EE7F1B41-F9AB-4B77-B3C0-D1D520C75E6CQ39027835-D4BBB55B-2A6A-4F48-A619-510C9EFD733DQ40039417-434429D8-1C7F-4BDA-96B2-43BB3FC51342Q40125073-894B2E26-9466-4902-969F-79B0FD13AFDEQ40242721-829B9ECE-BF37-46FA-BF3A-B86EFDC41A68Q40272378-05253A80-9D19-40F5-939F-EC49E33A362EQ40315460-06257A30-A1EB-4861-8F71-8DA0856DC691Q40421024-C5FC698D-B23E-43ED-B192-6153519EB4D6Q40489254-7E0F5163-0975-463C-9958-649D3BA4F520Q41956037-345D4114-9650-4161-A63A-5B0CCF914C7AQ47576552-985AA4D1-E912-4061-A801-E41B5DCD4353Q50493340-5F24F93F-AA2A-42B3-9B22-AB70CDCA2CACQ53136863-BBE8C717-293C-401E-AF6B-5C1B01BB7FACQ54942919-50AAF978-66BB-4673-97CE-85C488512BDC
P2860
Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Evaluation of risk prediction ...... penia in children with cancer.
@en
Evaluation of risk prediction ...... penia in children with cancer.
@nl
type
label
Evaluation of risk prediction ...... penia in children with cancer.
@en
Evaluation of risk prediction ...... penia in children with cancer.
@nl
prefLabel
Evaluation of risk prediction ...... penia in children with cancer.
@en
Evaluation of risk prediction ...... penia in children with cancer.
@nl
P2093
P1476
Evaluation of risk prediction ...... penia in children with cancer.
@en
P2093
Kelly C Wade
Patricia L Hibberd
Sarah W Alexander
Susan K Parsons
P356
10.1097/00043426-200201000-00011
P577
2002-01-01T00:00:00Z